Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

GSK's new pharma head to join in September after AstraZeneca tussle
Yahoo/Reuters
Mon, 06/19/17 - 11:34 pm
Tags:
GSK, AstraZeneca, Luke Miels
New test may turn AZ's Lynparza into precision drug for prostate cancer
Yahoo/Reuters
Mon, 06/19/17 - 12:11 am
Tags:
AstraZeneca, Lynparza, prostate cancer
Can AstraZeneca Keep Up As Clovis, Tesaro Unveil Blockbuster Drugs?
Investors Business Daily
Mon, 06/19/17 - 12:09 am
Tags:
AstraZeneca, Clovis, Tesaro, PARP inhibitors
AstraZeneca, Boehringer cry 'no class effect' after Johnson & Johnson's Invokana doubles amputations in study
Fierce Pharma
Wed, 06/14/17 - 09:00 pm
Tags:
AstraZeneca, Boehringer Ingelheim, JNJ, Invokana, diabetes, Jardiance, amputation
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
Tags:
diabetes, Merck, Pfizer, SGLT2 inhibitor, Januvia, Invokana, Farxiga, Jardiance, Eli Lilly, Boehringer Ingelheim, AstraZeneca, JNJ
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall
Xconomy
Mon, 06/12/17 - 10:08 pm
Tags:
Regulus, AstraZeneca
AstraZeneca to sell Zomig migraine drug rights
Marketwatch
Wed, 06/7/17 - 12:15 pm
Tags:
AstraZeneca, Zomig, migraines, Grunenthal, M&A
ASCO17: AstraZeneca pumps up expectations on near-term cancer drug wins, looking to shed a rep for failure
Endpoints
Tue, 06/6/17 - 09:44 am
Tags:
AstraZeneca, ASCO 2017, Lynparza, breast cancer
AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42%
Forbes
Sun, 06/4/17 - 11:53 am
Tags:
AstraZeneca, Lynparza, breast cancer, BRCA-mutant breast cancer, ASCO 2017
EMA recommends 11 drugs for approval in May meeting
BioPharma Dive
Thu, 05/25/17 - 09:26 am
Tags:
EMA, Europe, Sanofi, AstraZeneca, LEO Pharma, Novartis, Pfizer
AZ's Bydureon cleared a heart safety test, but didn't cut risks. Can it still vie with Novo?
Fierce Pharma
Tue, 05/23/17 - 08:17 am
Tags:
AstraZeneca, Bydureon, diabetes, Novo Nordisk, Victoza
AstraZeneca's new benralizumab helps severe asthma patients cut back on steroids
Fierce Pharma
Mon, 05/22/17 - 07:44 pm
Tags:
AstraZeneca, benralizumab, severe asthma, asthma, Zonda
AZ's controversial castoffs continue with $300M heart-med sale to Recordati
Fierce Pharma
Mon, 05/22/17 - 09:54 am
Tags:
AstraZeneca, Recordati, Logimax
AstraZeneca throws a monkey wrench in new GSK CEO’s first hiring decision, suing Luke Miels
Endpoints
Tue, 05/16/17 - 11:31 am
Tags:
GSK, Pharma CEOs, Emma Walmsley, AstraZeneca, Luke Miels
AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next
Forbes
Fri, 05/12/17 - 11:44 am
Tags:
AstraZeneca, oncology, Imfinzi, Opdivo, Keytruda
AstraZeneca’s shares spike on positive PhIII lung cancer data — but it’s not MYSTIC
Endpoints
Fri, 05/12/17 - 09:40 am
Tags:
AstraZeneca, clinical trials, durvalumab, Imfinzi, non-small cell lung cancer
AstraZeneca’s PhIII bid on asthma drug tralokinumab flops, and that’s no surprise
Endpoints
Wed, 05/10/17 - 09:38 am
Tags:
AstraZeneca, asthma, tralokinumab, clinical trials
Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town
Fierce Pharma
Wed, 05/10/17 - 09:31 am
Tags:
Pfizer, Merck KGaA, AstraZeneca, Bavencio, avelumab, bladder cancer, Imfinzi, FDA, Opdivo, Tecentriq
AstraZeneca's New Drug: Too Little, Too Late?
Seeking Alpha
Mon, 05/8/17 - 09:51 pm
Tags:
AstraZeneca, Imfinzi, bladder cancer
Pieris, AstraZeneca ink $45m deal for inhaled respiratory drugs
Drug Delivery Business News
Thu, 05/4/17 - 09:43 am
Tags:
Pieris, AstraZeneca, Respiratory

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.